Chimera Investment Corp

CIM remains in a Stage 4 decline within a clear downtrend, confirmed by active support failure and a lower-highs, lower-lows pattern. Price is extended below falling EMAs and key moving averages, while RSI and Options Score sit in extreme oversold, elevating bounce risk. Given the bearish medium-term structure but unfavorable timing for fresh shorts, the preferred approach is to trim into rallies up to the 9/21 EMA band and 50 DMA. We will reassess if price sustains a meaningful reclaim of the short-term EMAs with follow-through.

• ↑EAD $0.54/share covers $0.45 dividend by 1.2×, supporting a 3.89% yield.
• ↑Home Express origination up 39% YoY to $884M, fueling accretive growth.
• ↓Leverage ratio at 5.2× heightens refinancing and liquidity management risks.